Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
  NCT06427941 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Zion